These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22964750)

  • 1. Terminal-restriction fragment length polymorphism (T-RFLP) analysis for changes in the gut microbiota profiles of indomethacin- and rebamipide-treated mice.
    Imaeda H; Fujimoto T; Takahashi K; Kasumi E; Fujiyama Y; Andoh A
    Digestion; 2012; 86(3):250-7. PubMed ID: 22964750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebamipide inhibits indomethacin-induced small intestinal injury: possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5.
    Tanigawa T; Watanabe T; Otani K; Nadatani Y; Ohkawa F; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    Eur J Pharmacol; 2013 Mar; 704(1-3):64-9. PubMed ID: 23428631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between terminal-restriction fragment length polymorphism (T-RFLP) and quantitative culture for analysis of infants' gut microbiota.
    Sjöberg F; Nowrouzian F; Rangel I; Hannoun C; Moore E; Adlerberth I; Wold AE
    J Microbiol Methods; 2013 Jul; 94(1):37-46. PubMed ID: 23583598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebamipide Alters the Esophageal Microbiome and Reduces the Incidence of Barrett's Esophagus in a Rat Model.
    Kohata Y; Nakahara K; Tanigawa T; Yamagami H; Shiba M; Watanabe T; Tominaga K; Fujiwara Y; Arakawa T
    Dig Dis Sci; 2015 Sep; 60(9):2654-61. PubMed ID: 25862640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of cefixime-induced gut microbiota changes by Lactobacillus cocktails and fructooligosaccharides in a mouse model.
    Shi Y; Zhai Q; Li D; Mao B; Liu X; Zhao J; Zhang H; Chen W
    Microbiol Res; 2017 Jul; 200():14-24. PubMed ID: 28527760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-specific colitis susceptibility in IL10-deficient mice depends on complex gut microbiota-host interactions.
    Büchler G; Wos-Oxley ML; Smoczek A; Zschemisch NH; Neumann D; Pieper DH; Hedrich HJ; Bleich A
    Inflamm Bowel Dis; 2012 May; 18(5):943-54. PubMed ID: 22238116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats.
    Terán-Ventura E; Aguilera M; Vergara P; Martínez V
    J Crohns Colitis; 2014 Sep; 8(9):1043-54. PubMed ID: 24566169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota.
    Tanigawa T; Watanabe T; Higashimori A; Shimada S; Kitamura H; Kuzumoto T; Nadatani Y; Otani K; Fukunaga S; Hosomi S; Tanaka F; Kamata N; Nagami Y; Taira K; Shiba M; Suda W; Hattori M; Fujiwara Y
    PLoS One; 2021; 16(1):e0245995. PubMed ID: 33507971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
    Aomatsu T; Imaeda H; Fujimoto T; Takahashi K; Yoden A; Tamai H; Fujiyama Y; Andoh A
    Digestion; 2012; 86(2):129-35. PubMed ID: 22846404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease.
    Emoto T; Yamashita T; Kobayashi T; Sasaki N; Hirota Y; Hayashi T; So A; Kasahara K; Yodoi K; Matsumoto T; Mizoguchi T; Ogawa W; Hirata KI
    Heart Vessels; 2017 Jan; 32(1):39-46. PubMed ID: 27125213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mucosa-associated bacterial communities of the mouse intestine by terminal restriction fragment length polymorphism: Utility of sampling strategies and methods to reduce single-stranded DNA artifacts.
    Costa E; Puhl NJ; Selinger LB; Inglis GD
    J Microbiol Methods; 2009 Aug; 78(2):175-80. PubMed ID: 19463863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the gut microbiota of identical twins with Crohn's disease.
    Dicksved J; Halfvarson J; Rosenquist M; Järnerot G; Tysk C; Apajalahti J; Engstrand L; Jansson JK
    ISME J; 2008 Jul; 2(7):716-27. PubMed ID: 18401439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.
    Higashimura Y; Naito Y; Takagi T; Uchiyama K; Mizushima K; Ushiroda C; Ohnogi H; Kudo Y; Yasui M; Inui S; Hisada T; Honda A; Matsuzaki Y; Yoshikawa T
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G367-75. PubMed ID: 26767984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a probiotic, inulin, or their combination on the piglets' microbiota at different intestinal locations.
    Sattler VA; Bayer K; Schatzmayr G; Haslberger AG; Klose V
    Benef Microbes; 2015; 6(4):473-83. PubMed ID: 25380797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of proton pump inhibitor or rebamipide use on gut microbiota of rheumatoid arthritis patients.
    Kim JW; Jeong Y; Park SJ; Jin H; Lee J; Ju JH; Ji GE; Park SH
    Rheumatology (Oxford); 2021 Feb; 60(2):708-716. PubMed ID: 32789440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebamipide ameliorates indomethacin-induced small intestinal injury in rats via the inhibition of matrix metalloproteinases activity.
    Yamada S; Naito Y; Takagi T; Mizushima K; Horie R; Fukumoto K; Inoue K; Harusato A; Uchiyama K; Handa O; Yagi N; Ichikawa H; Yoshikawa T
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1816-24. PubMed ID: 23020299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition.
    Mar JS; Nagalingam NA; Song Y; Onizawa M; Lee JW; Lynch SV
    Gut Microbes; 2014 Jul; 5(4):494-503. PubMed ID: 25144681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation of the murine cecal microbiota as revealed by terminal restriction fragment length polymorphism and 16S rRNA gene clone libraries.
    Kibe R; Sakamoto M; Hayashi H; Yokota H; Benno Y
    FEMS Microbiol Lett; 2004 Jun; 235(1):139-46. PubMed ID: 15158273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.
    Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracolony variation of bacterial gut microbiota among castes and ages in the fungus-growing termite Macrotermes gilvus.
    Hongoh Y; Ekpornprasit L; Inoue T; Moriya S; Trakulnaleamsai S; Ohkuma M; Noparatnaraporn N; Kudo T
    Mol Ecol; 2006 Feb; 15(2):505-16. PubMed ID: 16448416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.